(Q37270033)

19 August 2017

HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer (English)

1 reference

19 August 2017

1 reference

1 reference

9

Brian J Czerniecki

1 reference

19 August 2017

1

Robert E Roses

1 reference

19 August 2017

E Carter Paulson

2

1 reference

19 August 2017

Anupama Sharma

3

1 reference

19 August 2017

Jeanne E Schueller

4

1 reference

19 August 2017

Harvey Nisenbaum

5

1 reference

19 August 2017

Susan Weinstein

6

1 reference

19 August 2017

Kevin R Fox

7

1 reference

19 August 2017

Paul J Zhang

8

1 reference

19 August 2017

language of work or name

1 reference

21 April 2009

1 reference

Cancer Epidemiology, Biomarkers & Prevention

19 August 2017

1 reference

19 August 2017

18

1 reference

19 August 2017

5

1 reference

19 August 2017

1386-1389

1 reference

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Effects of HER2 overexpression on cell signaling networks governing proliferation and migration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Detection of ductal carcinoma in situ in women undergoing screening mammography

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713817

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19383888

12 December 2020

inferred from PubMed ID database lookup

Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19383888

12 December 2020

inferred from PubMed ID database lookup

In situ and invasive components of mammary adenocarcinoma: comparison of Her-2/neu status

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19383888

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1158/1055-9965.EPI-08-1101

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slq4d3d4djgrvkx5zks5oawz44

30 July 2022

release_slq4d3d4djgrvkx5zks5oawz44

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slq4d3d4djgrvkx5zks5oawz44

30 July 2022

https://api.fatcat.wiki/v0/release/slq4d3d4djgrvkx5zks5oawz44

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/slq4d3d4djgrvkx5zks5oawz44

PubMed publication ID

1 reference

30 July 2022